Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
A discrete choice experiment to explore societal preferences (of parents and pediatricians) regarding the attributes of a MenB vaccine in Spain.
Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain
Cost-effectiveness analysis of triple therapy Budesonide/ Glycopyrronium/ Formoterol fumarate versus dual therapies LAMA/LABA and ICS/LABA in COPD patients from the perspective of the Spanish National Health System.
Cost-consequence analysis for recombinant human growth hormone treatment administered via different devices in children in Spain
Comparing height gain and treatment costs of the treatment with recombinant human growth hormone (r-hGH), administered either by Easypod® or other conventional devices licensed in Spain (non-Easypod®) in children and adolescents with growth hormone deficiency.
Análisis de los costes asociados al seguimiento de pacientes con VIH que discontinúan el tratamiento antirretroviral por falta de eficacia o toxicidad inaceptable en España
Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain compared to the costs involved in the routine follow-up of patients on antiretroviral treatment.
Management of prediabetes from the perspective of Spanish physicians and community pharmacists: Detecta2 study
The study describes routine clinical practice and the views of physicians and pharmacists on prediabetes Management in Spain.
La nueva Dermalidad. Conocer el modelo asistencial de la psoriasis para avanzar en su abordaje.
Identification and prioritisation of current challenges and needs in the management of patients with psoriasis.
The impact of Patient Support Programs in Europe. A systematic literature review
A systematic review of the literature aimed at characterizing the evaluations of patient support programs. This is the first review, to our knowledge, that focuses on programs developed Europe and that followed the definition of the European Medicines Agency (EMA). Our results evidenced the need to standardize the definition of these programs as well as […]
Patient-Reported Outcome Measures in Real-World Atopic Dermatitis Studies inSpain: A Systematic Review
Identification and description of patient-reported outcome measures (PROM) used in observational studies of atopic dermatitis over the last decade in Spain.
Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer
Definition of the standard set of patient-reported outcomes (PROs) and the corresponding measures (PROMs) for patients with advanced ovarian cancer follow-up.
Co-designing a mHealth app for the collection of patient-reported outcomes in frail patients
Involvement of clinicians and patients in the design and development of a mobile application for the collection of patient-reported outcomes (PROs) in the frail population, within the framework of the Smartchronic project.
